114 related articles for article (PubMed ID: 7923004)
1. Parametric survival analysis of adjuvant therapy for stage II breast cancer.
Gamel JW; Vogel RL; Valagussa P; Bonadonna G
Cancer; 1994 Nov; 74(9):2483-90. PubMed ID: 7923004
[TBL] [Abstract][Full Text] [Related]
2. Refined measurement of outcome for adjuvant breast carcinoma therapy.
Gamel JW; Bonadonna G; Valagussa P; Edwards MJ
Cancer; 2003 Mar; 97(5):1139-46. PubMed ID: 12599218
[TBL] [Abstract][Full Text] [Related]
3. Assessing the impact of adjuvant therapy on cure rate for stage 2 breast carcinoma.
Gamel JW; Vogel RL; McLean IW
Br J Cancer; 1993 Jul; 68(1):115-8. PubMed ID: 8318401
[TBL] [Abstract][Full Text] [Related]
4. A model of long-term survival following adjuvant therapy for stage 2 breast cancer.
Gamel JW; Vogel RL
Br J Cancer; 1993 Dec; 68(6):1167-70. PubMed ID: 8260368
[TBL] [Abstract][Full Text] [Related]
5. The impact of stage and histology on the long-term clinical course of 163,808 patients with breast carcinoma.
Gamel JW; Meyer JS; Feuer E; Miller BA
Cancer; 1996 Apr; 77(8):1459-64. PubMed ID: 8608529
[TBL] [Abstract][Full Text] [Related]
6. Survival Analysis of Patients with Breast Cancer using Weibull Parametric Model.
Baghestani AR; Moghaddam SS; Majd HA; Akbari ME; Nafissi N; Gohari K
Asian Pac J Cancer Prev; 2015; 16(18):8567-71. PubMed ID: 26745118
[TBL] [Abstract][Full Text] [Related]
7. Comparison of parametric and non-parametric survival methods using simulated clinical data.
Gamel JW; Vogel RL
Stat Med; 1997 Jul; 16(14):1629-43. PubMed ID: 9257417
[TBL] [Abstract][Full Text] [Related]
8. Applying conventional and saturated generalized gamma distributions in parametric survival analysis of breast cancer.
Yavari P; Abadi A; Amanpour F; Bajdik C
Asian Pac J Cancer Prev; 2012; 13(5):1829-31. PubMed ID: 22901130
[TBL] [Abstract][Full Text] [Related]
9. Is breast cancer curable: a study of long-term crude cumulative incidence.
Ambrogi F; Trevisi L; Martelli G; Boracchi P
Tumori; 2014; 100(4):406-14. PubMed ID: 25296589
[TBL] [Abstract][Full Text] [Related]
10. Cure models for estimating hospital-based breast cancer survival.
Rama R; Swaminathan R; Venkatesan P
Asian Pac J Cancer Prev; 2010; 11(2):387-91. PubMed ID: 20843121
[TBL] [Abstract][Full Text] [Related]
11. Life expectancy as a measurement of the benefit shown by clinical trials of treatment for early breast cancer.
Haybittle JL
Clin Oncol (R Coll Radiol); 1998; 10(2):92-4. PubMed ID: 9610897
[TBL] [Abstract][Full Text] [Related]
12. Neoadjuvant chemotherapy in stage III breast cancer.
Alassas M; Chu Q; Burton G; Ampil F; Mizell J; Li BD
Am Surg; 2005 Jun; 71(6):487-92. PubMed ID: 16044927
[TBL] [Abstract][Full Text] [Related]
13. A prognostic scoring model for survival after locoregional therapy in de novo stage IV breast cancer.
Kommalapati A; Tella SH; Goyal G; Ganti AK; Krishnamurthy J; Tandra PK
Breast Cancer Res Treat; 2018 Aug; 170(3):677-685. PubMed ID: 29721715
[TBL] [Abstract][Full Text] [Related]
14. A nonparametric mixture model for cure rate estimation.
Peng Y; Dear KB
Biometrics; 2000 Mar; 56(1):237-43. PubMed ID: 10783801
[TBL] [Abstract][Full Text] [Related]
15. Trastuzumab for patients with HER2 positive breast cancer: delivery, duration and combination therapies.
Pinto AC; Ades F; de Azambuja E; Piccart-Gebhart M
Breast; 2013 Aug; 22 Suppl 2():S152-5. PubMed ID: 24074778
[TBL] [Abstract][Full Text] [Related]
16. [New methods in the treatment of breast cancer].
Semiglazov VF
Vopr Onkol; 1997; 43(1):22-6. PubMed ID: 9133082
[TBL] [Abstract][Full Text] [Related]
17. Sector resection with or without postoperative radiotherapy for stage I breast cancer: five-year results of a randomized trial. Uppsala-Orebro Breast Cancer Study Group.
Liljegren G; Holmberg L; Adami HO; Westman G; Graffman S; Bergh J
J Natl Cancer Inst; 1994 May; 86(9):717-22. PubMed ID: 8158702
[TBL] [Abstract][Full Text] [Related]
18. Estimation of the cure rate in Iranian breast cancer patients.
Rahimzadeh M; Baghestani AR; Gohari MR; Pourhoseingholi MA
Asian Pac J Cancer Prev; 2014; 15(12):4839-42. PubMed ID: 24998549
[TBL] [Abstract][Full Text] [Related]
19. Survival effects of postmastectomy adjuvant radiation therapy using biologically equivalent doses: a clinical perspective.
Gebski V; Lagleva M; Keech A; Simes J; Langlands AO
J Natl Cancer Inst; 2006 Jan; 98(1):26-38. PubMed ID: 16391369
[TBL] [Abstract][Full Text] [Related]
20. Comparison Cure Rate Models by DIC Criteria in Breast Cancer Data.
Baghestani AR; Shahmirzalou P; Sayad S; Akbari ME; Zayeri F
Asian Pac J Cancer Prev; 2018 Jun; 19(6):1601-1606. PubMed ID: 29936785
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
